Sign In

Nina Dudnik

I build communities that support scientists and entrepreneurs to turn their ambitions into realities.

Nina Dudnik is a prominent figure in the realms of Innovation and Entrepreneurship, boasting over 20 years of experience in translating visionary ideas into tangible social and business impacts.

With a vast global network extending across startups, corporations, universities, governments, and NGOs, Nina excels in fostering transformative relationships among diverse entities to address unmet needs and drive substantial, measurable outcomes.

Her areas of expertise span from nurturing entrepreneurial ventures from their inception to achieving global reach, securing over $15 million in funding, and establishing programs in 34 countries.

In addition to her entrepreneurial prowess, Nina has a proven track record in team leadership, having efficiently managed teams ranging from 1 to 10+ individuals.

She is a trailblazer in developing cross-cultural and cross-sector educational initiatives for professionals in corporate and university settings, as well as adept at representing projects and organizations on a global stage.

Nina is known for her talent in forging innovative partnerships within an extensive international network that encompasses both public and private sectors, and for her ability to design and implement operational best practices and success metrics that drive both financial and societal impact.

Her professional journey has seen her navigate the intersections of government, corporate, and entrepreneurial landscapes, engaging with entities such as accelerators, incubators, government agencies, universities, and corporate innovation groups.

Nina Dudnik's academic background is as impressive as her professional achievements, with notable studies at institutions like ETHS, Harvard University for molecular biology and nucleosome assembly systems in Drosophila, and Brown University for biochemistry.

In her illustrious career, Nina has held key roles such as Chief Business Officer at BioLabs, Director of Policy and Transaction Development at MilliporeSigma, and Director of Life Science Strategy at MilliporeSigma.

She has also been recognized with prestigious accolades like the 2014 JFK New Frontier Award from the John F. Kennedy Library Foundation, and has been affiliated with esteemed organizations including PopTech, TED, Seeding Labs, Echoing Green, Harvard Medical School, Africa Rice Center, and Bioversity International.

Highlights

Aug 6 · linkedin

📣 It's time to #vote! 🗳

No, not in that election, not yet anyway.

I need your vote for our terrific panel suggestion for next year's South by Southwest #SXSW.

Go here to vote by August 18: https://lnkd.in/grVfDbn4

Your vote can send this #AllWOMENpanel (and all #Chicago!) - Nina Dudnik,(that's me), Lisa Dhar, Dimitra Georganopoulou, and Julie Ming Liang - to #SXSW in March to talk about the challenges - pro and con - of taking basic science out of the lab and turning it into #ventures and impact.

Thank you for supporting us!

May 10 · linkedin

Feeling thoroughly biologized! What a thrill to go to SynBioBeta this week. It's been exactly 5 years since the last time I attended, and it was fascinating to see how much had changed, and the core themes that kept recurring:

  • 5 years ago, enzymatic DNA synthesis was still an aspiration. Now it's a reality. I'm a dinosaur who hand-sequenced DNA once upon a time, so the ability to order DNA on demand from so many different companies made through so many different processes is how I know I'm living in the future.

  • There hadn't been serious commercial products from synbio 5 years ago, and I remember fielding accusations that maybe it was all fiction. Now we can point to alt-meats, food ingredients, and some materials that have gone mainstream, not to mention a few huge acquisitions that have given real proof to the ambitions.

  • I've rolled my eyes more than once at the buzzy use of AI. But I was drawn in by the new models being developed to understand genomes, predict protein folding, and hopefully design new enzymes with never-before-seen functions in the near future.

  • It was nice to see the collaboration between industry and government around issues of biosafety and regulation, getting out ahead of the issues instead of waiting for a crisis.

  • I may never recover emotionally from the failures in the late '90s to introduce GMO's to the public. There's a huge investment in alternative proteins and other ingredients as a means to mitigate the climate impacts of our food chain -- and we're going to need to do better on both public education and marketing to make sure they succeed. (I'm a little disappointed I didn't get to eat any bioengineered ice cream.)

Loved seeing so many old and new friends. Christina Agapakis, Michael Baffi, PhD, Ben Kellogg, Melina Fan, Will Kools, Michael Hallstrom, Florence Chaverneff, Sarah R. Carter, Ph.D., Yolanda F., Joseph Buccina, and the growing Chicago contingent: Katherine "Kit" McDonnell, Michael Köpke, Gerry Sapienza, Julie Ming Liang, Khalid K. Alam, Ph.D.

All in all, #synbio really convenes the bio-optimists, and I'm feeling hopeful about what this community is going to build next.

Nina Dudnik
Add to my network

Location

Greater Chicago Area